![]() |
市場調查報告書
商品編碼
1803077
全球乳製品檢測市場:預測(至 2032 年)-按檢測類型、產品類型、技術、最終用戶和地區進行分析Dairy Testing Market Forecasts to 2032 - Global Analysis By Test Type (Safety Testing and Quality Testing), Product Type, Technology, End User and By Geography |
根據 Stratistics MRC 的數據,全球乳製品檢測市場預計在 2025 年達到 75 億美元,到 2032 年將達到 148.1 億美元,預測期內的複合年成長率為 10.2%。
乳製品檢測是分析牛奶和乳製品以確保其品質、安全性和符合監管標準的過程。這包括檢測污染物、驗證營養成分以及評估成分、微生物品質和摻假等參數。乳製品檢測採用先進的分析技術,有助於保持產品的一致性、延長保存期限並保護消費者健康,同時幫助生產商滿足產業和政府對生產安全、高品質乳製品的要求。
據英國國家統計局稱,2022 年英國英國使用該系統對約 1,200 萬個樣本進行殘留檢測。
生牛奶摻假和污染增加
生鮮牛奶摻假是一個普遍存在的問題,尤其是在乳製品消費量高的地區。生鮮牛奶中常發現澱粉、清潔劑和合成化學物質等有害物質,構成嚴重的健康風險。為此,相關部門正在加強監管,並在生產和分銷管道實施更嚴格的檢測。這種轉變推動了對全面安全評估的需求,包括病原體和殘留物檢測。乳製品公司正在採用日益複雜的檢測系統,以滿足合規性並建立消費者信任。隨著公眾關注度的不斷提高,檢測正在從被動的安全措施轉變為主動的品管措施。
缺乏熟練的乳製品檢驗專業人員
乳製品產業持續面臨缺乏能夠勝任複雜乳製品檢測程序的合格人員的困境。許多開發中地區的食品安全技術培訓和教育仍然有限。小型生產商往往缺乏標準化檢測的專業知識,導致產品品質不穩定。技術純熟勞工的短缺也影響了檢測結果的準確性和可靠性,尤其是在微生物和化學分析方面。這種勞動力短缺減緩了檢測服務的擴展,並使法規遵循變得更加複雜。
提高營養品質意識
注重健康的消費者越來越重視乳製品的營養成分。因此,檢測營養成分和標籤的準確性正成為製造商的首要任務。都市區和年輕消費者尤其青睞潔淨標示、富含蛋白質和強化乳製品。監管機構要求更清晰的標籤,並敦促生產商透過嚴格的檢測來檢驗營養聲明。功能性乳製品的出現進一步增加了可靠營養分析的需求。這種日益成長的意識使乳製品檢測成為產品真實性和市場差異化的策略工具。
原料乳供應波動影響檢測需求
季節性波動、飼料短缺以及天氣相關的干擾往往會導致牛奶產量不穩定,影響進入檢測流程的產品數量。當供應下降時,加工商會減少產量或延遲品質檢查,導致檢查週期不穩定。這種不一致性會降低實驗室效率,並使檢測供應商的資源規劃變得複雜。小型酪農尤其容易受到影響,因為它們缺乏在供應衝擊期間維持穩定運作的緩衝能力。因此,牛奶供應的波動會導致檢測需求不穩定,並造成整個價值鏈效率低落。
疫情導致乳製品物流嚴重中斷,餐旅服務業需求下降,引發勞動力短缺。出行限制延誤了樣本採集和實驗室檢測,影響了整體效率。同時,消費者偏好轉向更安全的包裝乳製品,這增加了對嚴格檢測的需求。實驗室採取了應對措施,採用數位平台和遠端監控工具來維持營運。線上零售和追溯系統日益普及,使買家對產品安全充滿信心。
病原體檢測領域預計將在預測期內達到最大規模
預計病原體檢測領域將在預測期內佔據最大的市場佔有率,這得益於乳製品對先進病原體檢測的需求。監管壓力正推動產業朝向更快、更精準的工具發展,例如生物感測器、ELISA 和基於 PCR 的方法。實驗室晶片系統、自動化工作流程和即時監控等技術創新正日益普及。政府主導的生鮮乳安全計畫也正在推動早期檢測工作。綜上所述,這些發展使得病原體篩檢對於確保乳製品的完整性和保障公眾健康至關重要。
預計獨立測試實驗室部門在預測期內將實現最高的複合年成長率
預計獨立檢測領域將在預測期內達到最高成長率。這是因為在監管要求日益嚴格以及對污染日益擔憂的背景下,對公正且準確的分析的需求日益成長。越來越多的酪農生產商開始尋求第三方檢測實驗室的認證和可靠結果。這些實驗室整合了酶聯免疫吸附試驗 (ELISA)、生物感測器和微流體系統等尖端工具,以提高速度和準確性。數位化自動化、數據主導的洞察和遠端樣本採集等趨勢正在蓬勃發展。隨著公共檢測的減少,該行業正在轉向依賴認證的私人實驗室來確保合規性和安全性。
預計亞太地區將在預測期內佔據最大的市場佔有率,這得益於乳製品消費量的成長、更嚴格的安全法規以及日益成長的公共衛生問題。生物感測器、ELISA和基於PCR的工具等先進技術正被廣泛採用,以實現更快、更準確的診斷。人工智慧監控、自動化工作流程和遠端樣本採集等趨勢正在重塑檢測實踐。監管改革、實驗室擴建和策略聯盟等發展使得私人和機構實驗室對於保障全部區域酪農的品質至關重要。
預計北美將在預測期內實現最高的複合年成長率。這是由於日益成長的安全擔憂、反覆出現的污染案例以及更嚴格的法律規範。隨著聯邦原料乳監測計畫的縮減,人們越來越依賴認可的獨立實驗室。生物感測器、ELISA 和 PCR 等最尖端科技正被用於快速檢測病原體和毒素。關鍵趨勢包括即時監測、自動化系統和微流體平台。實驗室擴建、策略合作夥伴關係和高級分析等最新進展正在鞏固檢測作為乳製品品質保證的重要組成部分的地位。
According to Stratistics MRC, the Global Dairy Testing Market is accounted for $7.50 billion in 2025 and is expected to reach $14.81 billion by 2032 growing at a CAGR of 10.2% during the forecast period. Dairy testing is the process of analyzing milk and dairy products to ensure quality, safety, and compliance with regulatory standards. It involves detecting contaminants, verifying nutritional content, and assessing parameters such as composition, microbiological quality, and adulteration. Using advanced analytical techniques, dairy testing helps maintain product consistency, extend shelf life, and protect consumer health, while supporting producers in meeting industry and government requirements for safe and high-quality dairy production.
According to the U.K Office for National Statistics, approximately 12 million samples were tested for residue by the system in the U.K. in 2022.
Increasing incidence of milk adulteration and contamination
Milk adulteration is becoming a widespread issue, particularly in regions with high dairy consumption. Harmful substances like starch, detergents, and synthetic chemicals are frequently found in milk, posing serious health hazards. In response, authorities are tightening regulations and enforcing more rigorous testing across production and distribution channels. This shift is driving demand for comprehensive safety assessments, including pathogen and residue detection. Dairy companies are increasingly adopting advanced testing systems to meet compliance and build consumer confidence. As public concern grows, testing is transitioning from a reactive safeguard to a proactive quality control measure.
Lack of skilled professionals for dairy testing
The industry continues to struggle with a lack of qualified personnel capable of handling complex dairy testing procedures. In many developing areas, technical training and education in food safety remain limited. Small producers often lack the expertise to implement standardized testing, resulting in inconsistent product quality. The shortage of skilled workers also affects the accuracy and reliability of test results, particularly in microbiological and chemical analysis. This talent gap slows down the expansion of testing services and complicates regulatory adherence.
Growing awareness about nutritional quality
Health-conscious consumers are placing greater emphasis on the nutritional content of dairy products. As a result, testing for nutrient composition and label accuracy is becoming a key priority for manufacturers. Urban populations and younger buyers are especially drawn to clean-label, protein-rich, and fortified dairy options. Regulatory agencies are pushing for clearer labeling, prompting producers to validate their nutritional claims through precise testing. The emergence of functional dairy products further amplifies the need for robust nutrient analysis. This growing awareness positions dairy testing as a strategic tool for product credibility and market differentiation.
Fluctuations in raw milk supply affecting testing demand
Seasonal variations, feed shortages, and climate-related disruptions often lead to unpredictable milk yields, impacting the volume of products entering the testing pipeline. When supply dips, processors may reduce production or delay quality checks, leading to uneven testing cycles. This inconsistency hampers laboratory efficiency and complicates resource planning for testing providers. Smaller dairies are particularly vulnerable, as they lack buffer capacity to maintain steady operations during supply shocks. As a result, fluctuating raw milk supply undermines the stability of testing demand and creates operational inefficiencies across the value chain.
The pandemic caused major disruptions in dairy logistics, reduced demand from hospitality sectors, and led to workforce shortages. Restrictions on movement delayed sample collection and lab testing, affecting overall efficiency. At the same time, consumer preference shifted toward packaged and safer dairy products, increasing the need for stringent testing. Laboratories responded by adopting digital platforms and remote monitoring tools to maintain operations. Online retail and traceability systems gained traction, allowing buyers to verify product safety.
The pathogen testing segment is expected to be the largest during the forecast period
The pathogen testing segment is expected to account for the largest market share during the forecast period, due to the need for advanced pathogen testing in dairy products. Regulatory pressure is pushing the industry toward faster, more precise tools like biosensors, ELISA, and PCR-based methods. Innovations such as lab-on-chip systems, automated workflows, and real-time monitoring are gaining traction. Government-led milk safety programs are also boosting early detection efforts. Collectively, these developments are making pathogen screening essential for ensuring dairy integrity and safeguarding public health.
The independent laboratories segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the independent laboratories segment is predicted to witness the highest growth rate, driven by the need for impartial, high-accuracy analysis amid growing regulatory demands and contamination concerns. Dairy producers are turning to third-party labs for certified, dependable results. These facilities are integrating cutting-edge tools like ELISA, biosensors, and microfluidic systems to enhance speed and precision. Trends such as digital automation, data-driven insights, and remote sample collection are gaining momentum. With reduced public testing, industry trust is shifting toward accredited private labs for compliance and safety.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, owing to growing dairy consumption, stricter safety regulations, and increasing public health concerns. Advanced technologies such as biosensors, ELISA, and PCR-based tools are being widely adopted for faster, more accurate diagnostics. Trends like AI-enabled monitoring, automated workflows, and remote sample collection are reshaping testing practices. Developments like regulatory reforms, lab expansions, and strategic collaborations are positioning both private and institutional labs as essential players in safeguarding dairy quality across the region.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to heightened safety concerns, recurring contamination cases, and stricter regulatory frameworks. With federal milk surveillance programs scaled back, reliance on certified independent labs has surged. Cutting-edge technologies like biosensors, ELISA, and PCR are being deployed for rapid detection of pathogens and toxins. Key trends include real-time monitoring, automated systems, and microfluidic platforms. Recent developments such as lab expansions, strategic alliances, and advanced analytics are solidifying testing as a vital element of dairy quality assurance.
Key players in the market
Some of the key players in Dairy Testing Market include Eurofins Scientific, Agilent Technologies, Inc., SGS S.A., Bio-Rad Laboratories, Inc., Intertek Group plc, Charm Sciences, Inc., Bureau Veritas S.A., Thermo Fisher Scientific Inc., Merieux NutriSciences Corporation, TUV NORD GROUP, ALS Limited, TUV SUD, Neogen Corporation, Romer Labs Division Holding GmbH, and AsureQuality.
In July 2025, Thermo Fisher Scientific Inc. announced an expansion of their strategic partnership with Sanofi to enable additional U.S. drug product manufacturing. Under the agreement, Thermo Fisher will acquire Sanofi's steriles manufacturing site in Ridgefield, New Jersey and will continue to manufacture a portfolio of therapies for Sanofi.
In June 2025, Intertek has acquired an Automated Breathing Metabolic Simulator (ABMS) from ATOR Labs to further expand its respirator testing capabilities. One of only nine such systems in use globally, this cutting-edge technology empowers Intertek to deliver high-precision testing, accelerated development cycles, and streamlined compliance with global standards to respirator manufacturers, solidifying its leadership in respiratory protective device (RPD) testing.
In April 2025, Agilent Technologies Inc. announced its participation at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, Illinois. Innovative Agilent products and partnerships playing a crucial role in transforming cancer research, diagnostics.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.